Research graph
References from A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1126/science.1164097
10.1126/science.1164097 · External reference
10.1016/j.canlet.2019.12.010
10.1016/j.canlet.2019.12.010 · External reference
10.1158/1538-7445.am2012-3709
10.1158/1538-7445.am2012-3709 · External reference
Phosphorylation of recombinant human ATP : citrate lyase by cAMP-dependent protein kinase abolishes homotropic allosteric regulation of the enzyme by citrate and increases the enzyme activity
2000 · External reference
10.1016/j.heliyon.2020.e03910
10.1016/j.heliyon.2020.e03910 · External reference
10.1101/2020.01.20.910752
10.1101/2020.01.20.910752 · External reference
Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia
10.1016/j.apsb.2022.06.011 · 2023 · External reference
10.1016/j.cmet.2022.05.004
10.1016/j.cmet.2022.05.004 · External reference
ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis
10.1186/s12967-023-04431-w · 2023 · External reference
10.1158/0008-5472.can-08-1235
10.1158/0008-5472.can-08-1235 · External reference
ACLY: A biomarker of recurrence in breast cancer
10.1016/j.prp.2020.153076 · 2020 · External reference
10.18632/oncotarget.9666
10.18632/oncotarget.9666 · External reference
Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma
10.1038/s41419-024-06951-9 · 2024 · External reference
10.1158/2159-8290.cd-18-0567
10.1158/2159-8290.cd-18-0567 · External reference
10.1186/s13046-019-1391-9
10.1186/s13046-019-1391-9 · External reference
10.4049/immunohorizons.2200086
10.4049/immunohorizons.2200086 · External reference
10.1182/bloodadvances.2024013762
10.1182/bloodadvances.2024013762 · External reference
10.1016/j.bneo.2025.100069 · 2025 · Admitted local publication
Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
10.1186/s12967-019-1884-5 · 2019 · External reference
10.1016/j.ccr.2005.09.008
10.1016/j.ccr.2005.09.008 · External reference
10.1016/j.ccr.2005.09.008
10.1016/j.ccr.2005.09.008 · External reference
10.1042/bj3340113
10.1042/bj3340113 · External reference
10.1194/jlr.d900008-jlr200
10.1194/jlr.d900008-jlr200 · External reference
10.1038/s41586-019-1094-6
10.1038/s41586-019-1094-6 · External reference
10.1016/j.bioorg.2023.106933
10.1016/j.bioorg.2023.106933 · External reference
to treat hypercholesterolemia in patients with statin intolerance
1002 · External reference
10.1056/nejmoa2215024
10.1056/nejmoa2215024 · External reference
10.1038/s41586-025-09297-0
10.1038/s41586-025-09297-0 · External reference
10.1038/s41586-019-1095-5
10.1038/s41586-019-1095-5 · External reference
NPM-ALK Mediated Tyrosine Phosphorylation of ATP Citrate Lyase Regulates Lipid Metabolism and Promotes Oncogenesis of Anaplastic Large Cell Lymphoma
10.1182/blood.v126.23.465.465 · 2015 · External reference
Structure-guided discovery of potent acly inhibitors with therapeutic potential in ALK plus anaplastic large cell lymphoma and other hematologic malignancies
10.1182/blood-2025-6815 · 2025 · External reference
ACLY is the novel signaling target of PIP(2)/PIP(3) and Lyn in acute myeloid leukemia
10.1016/j.heliyon.2020.e03910 · 2020 · External reference
10.1158/1541-7786.mcr-12-0569
10.1158/1541-7786.mcr-12-0569 · External reference
10.3390/cancers17203389
10.3390/cancers17203389 · External reference
10.1016/j.canlet.2026.218488
10.1016/j.canlet.2026.218488 · External reference
10.1016/j.molcel.2021.05.008
10.1016/j.molcel.2021.05.008 · External reference
10.1126/scisignal.aaz8240
10.1126/scisignal.aaz8240 · External reference
Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer
10.1158/2767-9764.crc-23-0030 · 2023 · External reference
10.1158/1535-7163.mct-12-0095
10.1158/1535-7163.mct-12-0095 · External reference
10.1101/2023.03.27.534395
10.1101/2023.03.27.534395 · External reference
10.1002/0471250953.bi1311s27
10.1002/0471250953.bi1311s27 · External reference
10.1126/science.1164097
10.1126/science.1164097 · External reference
10.1016/j.celrep.2016.09.069
10.1016/j.celrep.2016.09.069 · External reference
Acetyl-CoA derived from hepatic mitochondrial fatty acid beta-oxidation aggravates inflammation by enhancing p65 acetylation
10.1016/j.isci.2021.103244 · 2021 · External reference
10.1084/jem.20231820
10.1084/jem.20231820 · External reference
10.1093/nar/gkae253
10.1093/nar/gkae253 · External reference
10.1126/science.aad0489
10.1126/science.aad0489 · External reference
10.1007/s00018-012-1252-6
10.1007/s00018-012-1252-6 · External reference
10.1038/s41467-024-52538-5
10.1038/s41467-024-52538-5 · External reference
10.1016/j.jbc.2024.107151
10.1016/j.jbc.2024.107151 · External reference
The Integrated Stress Response Pathway Coordinates Translational Control of Multiple Immune Checkpoints in Lung Cancer
10.1158/0008-5472.can-24-3844 · 2025 · External reference
10.1186/s13073-026-01668-0
10.1186/s13073-026-01668-0 · External reference
ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2alpha/ATF4/CHOP axis
10.1111/jcmm.16235 · 2021 · External reference
The integrated stress response effector GADD34 is repurposed by neurons to promote stimulus-induced translation
10.1016/j.celrep.2023.113670 · 2024 · External reference
10.3389/fcell.2024.1458716
10.3389/fcell.2024.1458716 · External reference
10.1126/sciadv.adi2465
10.1126/sciadv.adi2465 · External reference
Organelle stress in NLRP3 inflammasome: a central mediator of neurodegenerative diseases
10.1186/s13024-025-00922-0 · 2026 · External reference
10.1056/nejmoa1803917
10.1056/nejmoa1803917 · External reference
10.1038/ncomms13457
10.1038/ncomms13457 · External reference
10.1038/s41586-025-09297-0
10.1038/s41586-025-09297-0 · External reference
Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH
10.1016/j.cmet.2025.11.015 · 2026 · External reference
10.3390/cancers14112681
10.3390/cancers14112681 · External reference
PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma
10.1038/s43018-023-00635-7 · 2023 · External reference
10.3390/cancers12092492
10.3390/cancers12092492 · External reference
10.7554/elife.78654
10.7554/elife.78654 · External reference
Metabolic reprogramming by Acly inhibition using SB-204990 alters glucoregulation and modulates molecular mechanisms associated with aging
10.1038/s42003-023-04625-4 · 2023 · External reference
10.1016/j.ejmech.2018.09.001
10.1016/j.ejmech.2018.09.001 · External reference
PGC-1beta and ChREBP partner to cooperatively regulate hepatic lipogenesis in a glucose concentration-dependent manner
10.1016/j.molmet.2013.05.001 · 2013 · External reference
PGC1beta regulates multiple myeloma tumor growth through LDHA-mediated glycolytic metabolism
10.1002/1878-0261.12363 · 2018 · External reference
Brown fat ATP-citrate lyase links carbohydrate availability to thermogenesis and guards against metabolic stress
10.1038/s42255-024-01143-3 · 2024 · External reference
10.1038/s41467-026-74324-1
10.1038/s41467-026-74324-1 · External reference
Noncanonical TCA cycle fosters canonical TCA cycle and mitochondrial integrity in acute myeloid leukemia
10.1111/cas.16347 · 2025 · External reference
Lipid metabolism in homeostasis and disease
10.1038/s41392-025-02357-x · 2026 · External reference
10.1111/boc.201800014
10.1111/boc.201800014 · External reference
10.3390/ijms20092304
10.3390/ijms20092304 · External reference
10.4049/jimmunol.177.11.8095
10.4049/jimmunol.177.11.8095 · External reference
